Relafen 750 represents a compelling therapeutic choice within the biochemical pharmacy field , primarily targeting inflammation associated with osteoarthritis . Its action copyrights on the targeted inhibition of prostaglandin synthesis, an enzyme crucial for the synthesis of prostaglandins . Thi